Jun
2026
Shanghai New International Expo Center
Visit us
stand W2B02b, Pharma Ingredients

Zhejiang Langhua Pharmaceutical Co., Ltd.

About Us

Quality Compliance: Langhua has CFDA-GMP, EU-GMP, WHO-PQ and ANVISA-GMP certificates. Langhua robust GMP system can ensure the quality reliability for worldwide market. EHS Compliance: Langhua strong EHS system has became the benchmark in APIs industry in China. With the concept of “EHS by design”, langhua established the safety lab to ensure Risk-Free from lab, pilot to commercial production. Production Capacity: The sufficient capacity and new pilot, multifunction workshop will ensure the on-time delivery from KGs to Tons even hundred tons. Intellectual Property: Langhua respects customers’ IP and set up the IP protection policy to ensure Risk-Free of confidential information. Flexibility: Langhua has a flexible, project-driven approach to each request, targeting a custom-made solution fit for your purpose and requirements. The workshops are classified to fit different requirements based on product classification, to achieve quick switch with the support of planning team. Efficiency: The experienced management team with more than 30 years in API manufacture, combining the efficient project management programs, Langhua commits to the delivery of cost-effective project on time, on budget and to the expected quality standard. With the concept of “develop for production” and “Lab to Plant by same team”, langhua ensures the 100% success of scaling up and commercialization. Innovation: Langhua’s experienced R&D team engages to apply new technologies to realize your idea, to optimize the process to make product affordable. One-Stop Solution: With Strong R&D, sufficient production capacity, robust GMP and EHS system, Langhua can provide One-stop Solution of product lifecycle management, including ROS development, process development & optimization, scale-up, registration & validation batch through to commercial batch production.

  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
API Producer
Custom Manufacturing/Custom Synthesis
Contact info
  • Zhejiang Provincial Chemical and Medical Material , Base Linhai Zone, 317016, Taizhou, Zhejiang, China
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand W2B02b, Pharma Ingredients

Products Featured at CPHI & PMEC China 2026

  • Levofloxacin Hemihydrate

    Product Levofloxacin Hemihydrate

    Quinolones antibacterial product, anti-infective CEP , USDMF registered,Chinese NMPA approved. Supportive in multinational Registration.
  • Enrofloxacin

    Product Enrofloxacin

    Third generation Quinolones antibacterial products, veterinary use CEP and USDMF registered
  • Spironolactone

    Product Spironolactone

    cardiovascular system drugs CEP and USDMF registered
  • Ciprofloxacin Hydrochloride

    Product Ciprofloxacin Hydrochloride

    Wide-range antibacterialIndia registers
    China registered
  • Olanzapine

    Product Olanzapine

    USP-NF/EP11/CP2025DMF 

Zhejiang Langhua Pharmaceutical Co., Ltd. Resources (1)

  • Video Applications of Green Chemistry in API Production

    This webinar originally aired as part of CPHI Discover - 17-28 May 2021 Green Chemistry Overview Introduction to Green Chemistry- Twelve Principles and Examples Green Chemistry via Continuous Flow Advantages and Disadvantages Continuous flow reactors Continuous flow chemistry at Langhua